Accendra Health, Inc. beat EPS estimates 50% of the time across 2 reported quarters (1 beats, 1 misses), averaging -6.4% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $-0.13 | $-0.19 | -46.1% | Miss | Q2 FY26 call · transcript |
| Q1 FY26 | $-0.06 | $-0.04 | +33.3% | Beat | Q1 FY26 call · transcript |
| Q3 FY23 | not reported | $0.38 | not reported | not reported | |
| Q2 FY23 | not reported | $0.33 | not reported | not reported | |
| Q1 FY23 | not reported | $0.38 | not reported | not reported | |
| Q4 FY22 | not reported | $-0.08 | not reported | not reported | |
| Q3 FY22 | not reported | $0.11 | not reported | not reported | |
| Q2 FY22 | not reported | $0.53 | not reported | not reported | |
| Q1 FY22 | not reported | $0.37 | not reported | not reported | |
| Q4 FY21 | not reported | $-0.07 | not reported | not reported | |
| Q2 FY21 | not reported | $0.46 | not reported | not reported | |
| Q1 FY21 | not reported | $0.28 | not reported | not reported |
Back to ACH overview · ACH holders · ACH KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.